We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Epistem Announces Installation of UKs First Bruker Xtreme Imaging System
Product News

Epistem Announces Installation of UKs First Bruker Xtreme Imaging System

Epistem Announces Installation of UKs First Bruker Xtreme Imaging System
Product News

Epistem Announces Installation of UKs First Bruker Xtreme Imaging System


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Epistem Announces Installation of UKs First Bruker Xtreme Imaging System"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Epistem Holdings Plc has announced the successful installation of the Bruker Xtreme Imaging System within its contract research services division. This is the first such machine in the UK and will enable Epistem to expand both the range and throughput of its imaging services, particularly in the field of oncology.

The Bruker Xtreme provides high sensitivity luminescence, fluorescence, radio-isotopic and radiographic (X-ray) imaging. Combined with Epistem's specialized pre-clinical knowledge this increases the range of assays the company can provide to its clients as well as their ability to identify new targets for cancer therapy.

"We are excited to have installed the UKs first machine. This new platform combines highly sensitive capabilities in a unified system, and provides us with a means to track tumour cells, visualize inflammation, and provide high throughput pharmacodynamic studies." said Dr. Catherine Booth, Co-Founder and Managing Director of the Contract Services Business. "Epistem's contract research service is committed to providing high quality, reliable and innovative pre-clinical models and services."

Bruker commented "The successful installation of the Xtreme system at Epistem marks our first UK site. The Xtreme is a highly sensitive imaging system with the added advantages of modularity and flexibility. It's unique design will provide major benefits to Epistem's pre-clinical drug development services."

Advertisement